{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:38:18Z","timestamp":1785155898681,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":821,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004937","name":"Bundesministerium f\u00fcr Forschung und Technologie","doi-asserted-by":"publisher","award":["FKZ0316030"],"award-info":[{"award-number":["FKZ0316030"]}],"id":[{"id":"10.13039\/501100004937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004937","name":"Bundesministerium f\u00fcr Forschung und Technologie","doi-asserted-by":"publisher","award":["FKZ031A553"],"award-info":[{"award-number":["FKZ031A553"]}],"id":[{"id":"10.13039\/501100004937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1111\/jth.14646","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:50:13Z","timestamp":1570063813000},"page":"191-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)"],"prefix":"10.1016","volume":"18","author":[{"given":"Ralf","family":"Pasternack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"B\u00fcchold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"J\u00e4hnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Pelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Heil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Florian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6tz","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14646_bb0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/195911b0","article-title":"Accelerated lysis of blood clots","volume":"195","author":"Lorand","year":"1962","journal-title":"Nature"},{"key":"10.1111\/jth.14646_bb0015","doi-asserted-by":"crossref","first-page":"11930","DOI":"10.1002\/anie.201305133","article-title":"Structure of active coagulation factor XIII triggered by calcium binding: basis for the design of next\u2010generation anticoagulants","volume":"52","author":"Stieler","year":"2013","journal-title":"Angew Chemie Int Ed"},{"key":"10.1111\/jth.14646_bb0020","doi-asserted-by":"crossref","first-page":"10355","DOI":"10.1021\/jm501058g","article-title":"Novel insights into structure and function of factor XIIIa\u2010inhibitor tridegin","volume":"57","author":"B\u00f6hm","year":"2014","journal-title":"J Med Chem"},{"key":"10.1111\/jth.14646_bb0025","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1538-7836.2005.01213.x","article-title":"Factor XIII and the clotting of fibrinogen: from basic research to medicine","volume":"3","author":"Lorand","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14646_bb0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-0038-1642451","article-title":"Transglutaminases: protein cross\u2010linking enzymes in tissues and body fluids","volume":"71","author":"Aeschlimann","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14646_bb0035","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1152\/physrev.00016.2010","article-title":"Factor XIII: a coagulation factor with multiple plasmatic and cellular functions","volume":"91","author":"Muszbek","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1111\/jth.14646_bb0040","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1182\/blood-2015-06-652263","article-title":"Factor XIIIa\u2010dependent retention of red blood cells in clots is mediated by fibrin \u03b1\u2010chain crosslinking","volume":"126","author":"Byrnes","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.14646_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/01.ATV.20.1.2","article-title":"Research on clot stabilization provides clues for improving thrombolytic therapies","volume":"20","author":"Lorand","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14646_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1538-7836.2006.02182.x","article-title":"Factor XIII: recommended terms and abbreviations","volume":"5","author":"Muszbek","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14646_bb0055","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions","volume":"3","author":"Mosesson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14646_bb0060","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1182\/blood-2010-10-313601","article-title":"Interactions between factor XIII and the alphaC region of fibrinogen","volume":"117","author":"Smith","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.14646_bb0065","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1111\/febs.14272","article-title":"Activation of factor XIII is accompanied by a change in oligomerization state","volume":"284","author":"Anokhin","year":"2017","journal-title":"FEBS J"},{"key":"10.1111\/jth.14646_bb0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/jth.14412","article-title":"Factor XIII topology: organization of B subunits and changes with activation studied with single\u2010molecule atomic force microscopy","volume":"17","author":"Protopopova","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14646_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/378337a0","article-title":"The thrombin paradox","volume":"378","author":"Griffin","year":"1995","journal-title":"Nature"},{"key":"10.1111\/jth.14646_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fmed.2017.00019","article-title":"Factors XI and XII as targets for new anticoagulants","volume":"4","author":"Weitz","year":"2017","journal-title":"Front Med"},{"key":"10.1111\/jth.14646_bb0085","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1042\/bj3240797","article-title":"Tridegin, a new peptidic inhibitor of factor XIIIa, from the blood\u2010sucking leech Haementeria ghilianii","volume":"324","author":"Finney","year":"1997","journal-title":"Biochem J"},{"key":"10.1111\/jth.14646_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0049-3848(90)90267-G","article-title":"Enhanced thrombolysis by a factor XIIIa inhibitor in a rabbit model of femoral artery thrombosis","volume":"59","author":"Leidy","year":"1990","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14646_bb0095","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.V75.7.1455.1455","article-title":"Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue\u2010type plasminogen activator","volume":"75","author":"Shebuski","year":"1990","journal-title":"Blood"},{"key":"10.1111\/jth.14646_bb0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jpba.2004.12.032","article-title":"Pharmacokinetic studies of a novel 1,2,4\u2010thiadiazole derivative, inhibitor of Factor XIIIa, in the rabbit by a validated HPLC method","volume":"38","author":"Novakovic","year":"2005","journal-title":"J Pharm Biomed Anal"},{"key":"10.1111\/jth.14646_bb0105","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1021\/ja992355s","article-title":"Alutacenoic acids A and B, rare naturally occurring cyclopropenone derivatives isolated from fungi: potent Non\u2010peptide factor XIIIa inhibitors","volume":"122","author":"Kogen","year":"2000","journal-title":"J Am Chem Soc"},{"key":"10.1111\/jth.14646_bb0110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ab.2007.05.011","article-title":"A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma","volume":"367","author":"Oertel","year":"2007","journal-title":"Anal Biochem"},{"key":"10.1111\/jth.14646_bb0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0003-2697(71)90363-0","article-title":"Transamidating enzymes","volume":"44","author":"Lorand","year":"1971","journal-title":"Anal Biochem"},{"key":"10.1111\/jth.14646_bb0120","first-page":"S20","article-title":"Possibilities and limitations of thrombelastometry\/\u2010graphy","volume":"26","author":"Lang","year":"2006","journal-title":"Hamostaseologie"},{"key":"10.1111\/jth.14646_bb0125","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/pro.5560030720","article-title":"Transglutaminase factor XIII uses proteinase\u2010like catalytic triad to crosslink macromolecules","volume":"3","author":"Pedersen","year":"1994","journal-title":"Protein Sci"},{"key":"10.1111\/jth.14646_bb0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2015.05.008","article-title":"Setup and validation of shake\u2010flask procedures for the determination of partition coefficients (logD) from low drug amounts","volume":"76","author":"Andr\u00e9s","year":"2015","journal-title":"Eur J Pharm Sci"},{"key":"10.1111\/jth.14646_bb0135","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.1021\/bi00199a039","article-title":"Transglutaminase inhibition by 2\u2010[(2\u2010Oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation","volume":"33","author":"Freund","year":"1994","journal-title":"Biochemistry"},{"key":"10.1111\/jth.14646_bb0140","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1213\/ANE.0b013e3181b5a263","article-title":"In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood","volume":"109","author":"J\u00e1mbor","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1111\/jth.14646_bb0145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-0036-1571343","article-title":"Newly\u2010recognized roles of factor XIII in thrombosis","volume":"42","author":"Byrnes","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14646_bb0150","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1152\/jappl.1959.14.6.943","article-title":"Biologic assay of a thrombosis\u2010inducing activity in human serum","volume":"14","author":"Wessler","year":"1959","journal-title":"J Appl Physiol"},{"key":"10.1111\/jth.14646_bb0155","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta\u2010analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1111\/jth.14646_bb0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jth.12074","article-title":"New developments in the area of factor XIII","volume":"11","author":"Schroeder","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14646_bb0165","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1055\/s-0037-1615606","article-title":"Depletion of plasma factor XIII prevents disseminated intravascular coagulation\u2010induced organ damage","volume":"85","author":"Lee","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14646_bb0170","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/acs.jmedchem.6b01036","article-title":"Recent progress in the development of transglutaminase 2 (TGase2) inhibitors","volume":"60","author":"Song","year":"2017","journal-title":"J Med Chem"},{"key":"10.1111\/jth.14646_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/13543776.2016.1115836","article-title":"Transglutaminase inhibitors: a patent review","volume":"26","author":"Keillor","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"10.1111\/jth.14646_bb0180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/01.CIR.99.2.299","article-title":"The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism","volume":"99","author":"Reed","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/jth.14646_bb0185","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nbt.2020","article-title":"Discovery and development of telaprevir: an NS3\u20104A protease inhibitor for treating genotype 1 chronic hepatitis C virus","volume":"29","author":"Kwong","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1111\/jth.14646_bb0190","first-page":"22","article-title":"The discovery and development of boceprevir: a novel, first\u2010generation inhibitor of the hepatitis C virus NS3\/4A serine protease","volume":"1","author":"Howe","year":"2013","journal-title":"J Clin Transl Hepatol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14646","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14646","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622015768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622015768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:27:01Z","timestamp":1761535621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622015768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1538783622015768"],"URL":"https:\/\/doi.org\/10.1111\/jth.14646","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 The Authors. Journal of Thrombosis and Haemostasis. Published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}